Mukherjee, Aditi http://orcid.org/0000-0002-2208-9945
Hossain, Zakir
Erben, Esteban http://orcid.org/0000-0001-5179-7863
Ma, Shuai
Choi, Jun Yong http://orcid.org/0000-0001-8218-6440
Kim, Hee-Sook http://orcid.org/0000-0003-2289-7827
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI127562)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (SC2GM130470)
Article History
Received: 12 October 2022
Accepted: 30 June 2023
First Online: 20 July 2023
Competing interests
: The City University of New York, Rutgers, The State University of New Jersey, and Instituto de Investigaciones Biotecnológicas -Instituto Tecnologico de Chascomus Consejo de Investigaciones Cientificas y Tecnicas, Universidad Nacional De San Martin have filed a patent application relating to JC-229 in this work for the treatment of <i>Trypanosoma brucei</i> (patent application no.63428794 pending), with J.Y.C., Z.H., H.-S.K., A.M., and E.E. named as inventor. The remaining authors declare no competing interests.